APSR2026-200

 
Late-Breaking
Submitted
Oral Presentation
AO31-001
 
 
https://storage.unitedwebnetwork.com/files/1285/1213449-46903-APSR2026-200_440558.pptx
Format: PPTX Only
 
Format: PDF Only
08. Lung Cancer
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Ryo Karita * QST Hospital Department of Radiology Chiba Japan Chiba University Graduate School of Medicine Department of General Thoracic Surgery Chiba Japan
Mio Nakajima - QST Hospital Department of Radiology Chiba Japan
Shuri Aoki - The Cancer Institute Hospital, Japanese Foundation for Cancer Research Department of Radiation Oncology Tokyo Japan
Teruaki Mizobuchi - Social Welfare Organization Saiseikai Imperial Gift Foundation,Chibaken Saiseikai Narashino Hospital Department of General Thoracic Surgery Chiba Japan
Satoshi Ikeda - Kansai Medical University Hospital Department of Thoracic Oncology Osaka Japan
Kayoko Ohnishi - School of Medicine, International University of Health and Welfare Department of Radiology Chiba Japan
Masaru Wakatsuki - QST Hospital Department of Radiology Chiba Japan
Hidemi Suzuki - Chiba University Graduate School of Medicine Department of General Thoracic Surgery Chiba Japan
Hitoshi Ishikawa - QST Hospital Department of Radiology Chiba Japan
 
 
 
 
 
 
Presenting Author Details
Ryo
Karita
rkarita0705@gmail.com
+818067893541
31-40
Japan
Original Research
Comparison of Outcomes Between Surgery and Carbon-Ion Radiotherapy for Lung Cancer Complicated with Interstitial Lung Disease
Maximum 25 words
Abstract Content
It is challenging to treat lung cancer (LC) complicated with interstitial lung disease (ILD) due to its prevalence and the risk of acute exacerbation. This study aimed to compare the treatment outcomes of surgery and carbon-ion radiotherapy (CIRT) for LC complicated with ILD and to clarify treatment efficacy based on patient characteristics, particularly operability.
We analyzed patients with LC complicated by ILD (including clinical diagnosis) who underwent either surgery or CIRT between January 2014 and December 2020. We compared overall survival (OS), disease-free survival (DFS), and cancer-specific survival (CSS) using the Kaplan-Meier method and log-rank test. Subgroup analyses were stratified by surgical procedure (lobectomy, segmentectomy, wedge resection) and operability (CIRT-inoperable vs surgery).
The study included 72 patients in the surgery group and 50 in the CIRT group. The CIRT group was significantly older (median 75 vs 71.5 years, p=0.017) and had poorer pulmonary function (median % forced vital capacity: 80.0 vs 98.1, p<0.001, % diffusing capacity for carbon monoxide: 61.4 vs 75.5, p<0.001). The CIRT cohort included 43 (86%) medically inoperable cases and 7 (14%) operable cases. Comparing the 43 CIRT-inoperable patients with the surgery group, OS (median 28.6 vs 90.5 months, p<0.001) and DFS (median 20.3 vs 86.7 months, p<0.001) were significantly better in the surgery group. However, no significant difference was observed in CSS (median 65 months vs not reached, p=0.477). In the procedure-stratified analysis, while lobectomy and segmentectomy showed better OS, no significant OS difference was found between the wedge resection and CIRT groups (p=0.877).
In patients with LC complicated by ILD, CIRT can be an important treatment option for patients deemed inoperable or those who are poor candidates for major resections.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
carbon-ion radiotherapy, interstitial lung disease, surgery
maximum 3 keywords and no abbreviations, separated by commas
none
296